Can I read Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions on EtoBox?
Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions by Eianni Patrice De Jose is a document available to read on EtoBox.
What is Liver Disease in Alpha-1 Antitrypsin Deficiency: Current Approaches and Future Directions about?
A1ATD is the leading genetic cause of liver disease among children. It is a protein-folding disorder in which toxic insoluble ATZ proteins aggregate in the ER of hepatocytes leading to inflammation, fibrosis, cirrhosis, and increased risk of hepatocellular carcinoma. The absence of the normal A1AT serum protein also predisposes patients to pan lobar emphysema as adults. At this time, the only approved therapy for A1ATD-associated liver disease is orthotopic liver transplantation, which is curative. However,
- Author
- Eianni Patrice De Jose
- Language
- EN